HistoWiz

Accelerating histopathology for cancer research

  • Stage Full Product Ready
  • Industry Biotechnology
  • Location New York City, NY, USA
  • Currency USD
  • Founded June 2012
  • Employees 6
  • Website histowiz.com

Company Summary

HistoWiz is a histopathology company that processes tissue specimens, digitizes the results, and provides a proprietary platform for online viewing and sharing of the images for cancer researchers in academia and industry. Unlike academic core facilities and CROs, HistoWiz guarantees a 3-day turnaround time and provides global instant access to virtual slides, cancer pathology expertise, low-cost data management, and a cancer image database.

Team

  • Ke Cheng
    Founder and CEO

    Ke Cheng is an experienced cancer researcher with expertise in mouse histopathology of solid tumors and hematological malignancies. She received her PhD in cancer biology from Pier Paolo Pandolfi's lab at Harvard in 2009 and successfully led a team of pathologists and scientists from Harvard and MSKCC to complete several projects leading to 6 publications in journals such as Nature and Blood. She received a SNSF grant for her postdoctoral resea

  • Ke Cheng

Advisors

  • Kaiser Wahab, JD
    Lawyer
    Unconfirmed

Previous Investors

  • Nathan Savir
    Unconfirmed
    Mike Chester
    Unconfirmed
    Tom Cirrito
    Unconfirmed
  • Zhenfund LLC
    Unconfirmed

Starting a startup?

Join the world's largest startup network for guidance, tools, and fundraising opportunities.

Get Started for Free